CPA
KITE

Cowen Prime Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Cowen Prime Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-250
Closed -$14K – 323
2015
Q1 		$14K Buy
+250
New +$16.8K 0.01% 240

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cowen Prime Advisors's KITE Position: Q2 2015 in Review

Cowen Prime Advisors sold out of Kite Pharma, Inc. (KITE) in Q2 2015, closing a stake of 250 shares — an estimated $14K sold.

Cowen Prime Advisors first reported a position in KITE in Q1 2015 and held it in 1 quarter. The position peaked at $14K in Q1 2015. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

  • Cowen Prime Advisors reported no remaining Kite Pharma, Inc. position as of Q2 2015 after selling out during the quarter.
  • Cowen Prime Advisors sold 250 Kite Pharma, Inc. shares in Q2 2015, an estimated $14K.
  • Cowen Prime Advisors first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 1 quarter.
  • Cowen Prime Advisors's Kite Pharma, Inc. position peaked at $14K in Q1 2015.
  • 155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on Cowen Prime Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.